John Hunter
Chief Tech/Sci/R&D Officer bij FIBROGEN, INC.
Profiel
John Hunter is currently the Chief Scientific Officer at FibroGen, Inc. He previously worked as a Senior Director at XOMA Corp., Chief Scientific Officer at Compugen Ltd., Vice President-Antibody R&D at Compugen, Inc. (United States), and Chief Executive & Scientific Officer at Keyhole Therapeutics, Inc. Dr. Hunter received his undergraduate degree from Hartwick College and his doctorate from The University of California, San Francisco.
Actieve functies van John Hunter
| Bedrijven | Functie | Begin |
|---|---|---|
| FIBROGEN, INC. | Chief Tech/Sci/R&D Officer | 12-07-2021 |
Eerdere bekende functies van John Hunter
| Bedrijven | Functie | Einde |
|---|---|---|
| XOMA CORPORATION | Director/Board Member | - |
| COMPUGEN LTD. | Chief Tech/Sci/R&D Officer | - |
| Keyhole Therapeutics, Inc. | Chief Executive Officer | - |
| Compugen, Inc. (United States) | Corporate Officer/Principal | - |
Opleiding van John Hunter
| Hartwick College | Undergraduate Degree |
| The University of California, San Francisco | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| XOMA CORPORATION | Health Technology |
| COMPUGEN LTD. | Health Technology |
| FIBROGEN, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
| Compugen, Inc. (United States) | |
| Keyhole Therapeutics, Inc. |
